Cutting-edge technology
Novel injectable biosensor for continuous remote monitoring of cancer patients at high-risk of relapse
The Leading Team
A consortium led by an SME with co-promoters from the North region of Portugal and an international partner.
SENTINEL aims at developing a minimally invasive and biocompatible implantable biosensor to be used in the early tumor surveillance in post-operative prostate cancer patients.
Placed under the user’s skin, the sensor allows optical readout of the patient’s disease state using a portable probe, which acquired signals are then analysed using machine learning algorithms to infer the disease status.
